International Genetic Testing Market 2018 | Key Players: Abbott Laboratories, Bio-Rad Laboratories, Inc., Illumina Inc., Myriad Genetic, PerkinElmer, QIAGEN N.V., and Quest Diagnostics

The, Genetic Testing Market inquire about report is developing with the quick pace; chiefly due the prospering Healthcare Sector. As per a current report distributed by the Market Research Future, The Genetic Testing Industry Research report is blasting and anticipated that would pick up unmistakable quality over the conjecture time frame. The Market is anticipated to exhibit a colossal development by 2023, outperforming its past development records as far as esteem and volume.

You can get easy access to sample report here, please click: https://www.marketresearchfuture.com/sample_request/2009 .

The Global Genetic testing market is growing moderately. It is growing at the CAGR of ~9.8% during the forecast period. The global genetic testing market expected to reach USD 10,033.4 million by 2023 from USD 4,683 in 2016.

Regional Analysis:
Americas accounted for the largest 46.3 % market share of the global genetic testing in 2016. The Americas market was ruled by the U.S. owing to its large economy, developed healthcare infrastructure and the compulsory genetic testing of newborns under the Affordable Healthcare Act.

Europe region was dominated by Germany, France and the U.K. which is estimated to reach USD 2.5 billion by the end of forecast period of 2023. The orphan drug classification coupled with the presence of large players and high per capita income of the European nations propel the Europe genetic testing market.

Asia-Pacific (APAC) region is expected to deliver the fastest growth at a CAGR of 10.1 % during the forecast period. Middle East and Africa (ME&A) is likely generate moderate growth skewed in favour opf the Gulf economies of Saudi Arabia, UAE and others. Poor economy, limited healthcare and political instability hamper the Africa genetic testing market.

Dominant Players:
Some of the dominant players in this market are Qiagen N.V. (Germany), PerkinElmer Inc. (US), Abbott Laboratories (US), Illumina Inc. (US), Bio-Rad Laboratories, Inc. (US), Myriad Genetics (US), and Quest Diagnostics (US) and others.

Market Scenario:
Genetic testing or DNA testing, is employed for the determination of bloodlines and the diagnosis and prognosis of genetic diseases so as to select appropriate treatment regimens. The global genetic testing market is generating a CAGR of ~9.8% and is expected to reach USD 10.0 billion by the end of the forecast period 2016-2023.

Market Dynamics:
Drivers:
The growing demand for genetic testing from end industries and users such as diagnostics, drug discovery, research and development, livestock and others are the prime drivers of the market. Rising awareness, growing demand for parentage determination, progeny testing in livestock and agriculture, seed industries, and growing incidence and prevalence of cancers, and others are further charging the market.
Technological advancements such as the development of through output screening, next generation screening (NGS), growing sensitivity and selectivity of tests, improvements in analytics resulting in faster detection, development of tissue microarray techniques are technical drivers of the market. Further forensic testing is firing the demand for advanced tests which is benefiting the market.

Any query or specific requirement? Ask to our industry expert, please click: https://www.marketresearchfuture.com/enquiry/2009 .

Restraints:
High cost of the tests, lack of awareness in underdeveloped regions and the possibility of genetic discrimination hampers the market.
Genetic testing provides limited information about an inherited disease. A person may only be a carrier of a disorder, displaying low or no symptoms. Genetic testing also does not determine the timely progression of the disorder and thereby results in ambiguity of treatment strategies for genetic disorders.

Segments:
The global genetic testing market has been divided by type, method, type of test, indication and regions to gain an accurate assessment of the direction of the market.

Type - prescribed genetic testing, and direct to consumer (DTC) genetic testing. Prescribed genetic testing dominated the market in 2016.

Method - molecular genetic test/ DNA test, biochemical genetic test, chromosomal genetic test. Molecular genetic tests/DNA accounted for the largest market share in 2016.

Type of test - diagnostic test, family DNA test, predictive test, and others. Diagnostic test possessed the largest market share in 2016.

Indication - cancer testing, autoimmune disorder testing, neurogenetic disorder testing, muscular dystrophies, and others. Cancer testing had the largest market share in 2016.

Regions – Americas, Europe, Asia-Pacific (APAC), and Middle East and Africa (ME&A)

Industry News:
Feb, 2018 - Optra Health launched 'Digital Genetic Assistant' for interpreting genetic tests.

Jun, 2017 - Phosphorus launched diagnostic genetic tests for hereditary cancers designed to provide lifetime risk quantification, which are expected to drive down survival rates.

Jan, 2017 - Elucigene Diagnostics launched CF-DE test for the genetic detection of cystic fibrosis.

What makes our report unique?
1) An extensive research study on the Global Genetic Testing market, and its entire ecosystem, describes the market trends, drivers, restraints and opportunities of the Genetic Testing market.

2) We provide you the longest possible market segmentation based on type of products, procedures and geography and describe the market share region wise.

3) The report gives a bird eyes view on the competitive landscape which includes mergers and acquisitions, collaborations, market strategies, and new product launches.

…CONTINUED For TOC

Feel free to get in touch for discounts and customized details: https://www.marketresearchfuture.com/check-discount/2009 .

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com

This release was published on openPR.